Dynavax Technologies Corporation Capital Reinvestment Ratio
Dynavax Technologies Corporation capital reinvestment ratio. Dynavax Technologies Corporation (DVAX) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow ($33.83 Million) in capital expenditures ($1.24 Million). See Dynavax Technologies Corporation free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dynavax Technologies Corporation (2021–2024)
Capital reinvestment ratio of Dynavax Technologies Corporation from 2021 to 2024. This chart tracks Dynavax Technologies Corporation's Capital Reinvestment Ratio across 4 annual periods. See Dynavax Technologies Corporation leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Dynavax Technologies Corporation Capital Reinvestment Ratio by Year (2021–2024)
Dynavax Technologies Corporation capital reinvestment ratio by year from 2021 to 2024. For the full cash flow conversion analysis, see DVAX cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | $66.51 Million | $6.35 Million | ▲ +134.0% |
| 2023 | 0.04x | $100.56 Million | $4.10 Million | ▼ -64.1% |
| 2022 | 0.11x | $62.72 Million | $7.14 Million | ▲ +303.0% |
| 2021 | 0.03x | $335.53 Million | $9.48 Million | — |